Cadence Raises $100M Series C

Cadence, a clinical AI company based in New York, announced a $100 million Series C funding round to scale its AI-powered care model for managing chronic disease. The company, which specializes in automating chronic care for older adults, has seen rapid adoption across more than 20 leading health systems and aims to address the significant clinician shortage in the United States.

Investors

This round was led by Spark Capital. Participating investors included Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, and Duke Health.

Cadence Use of Funds

Cadence plans to use the new capital to expand its operations across additional health systems, advance its clinical AI agents, and increase growth in value-based care models.

About Cadence

Founded by Chris Altchek, Cadence is a clinical AI company focused on automating the treatment of chronic disease. Their platform integrates directly into electronic medical records and clinical workflows to monitor patient vitals, support medication adjustments, and enable personalized lifestyle coaching to improve health outcomes and reduce costs.

Funding Details

Company Website: https://cadence.care

Company: Cadence
Raised: $100M
Round: Series C
Funding Date: June 23, 2026
Lead Investor: Spark Capital
Additional Investors: Thrive Capital, General Catalyst, Coatue, B Capital, Corewell Health Ventures, Memorial Hermann, Duke Health
Company Website: www.cadence.care
Software Category: Healthcare AI
Source: https://www.businesswire.com/news/home/20260623072271/en/Cadence-Raises-%24100M-Series-C-Led-by-Spark-Capital-to-Automate-Chronic-Care